Works by Eiber, Matthias


Results: 331
    1
    2
    3

    Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.

    Published in:
    BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1478-4
    By:
    • Thalgott, Mark;
    • Rack, Brigitte;
    • Eiber, Matthias;
    • Souvatzoglou, Michael;
    • Heck, Matthias M.;
    • Kronester, Caroline;
    • Andergassen, Ulrich;
    • Kehl, Victoria;
    • Krause, Bernd J.;
    • Gschwend, Jurgen E.;
    • Retz, Margitta;
    • Nawroth, Roman
    Publication type:
    Article
    4
    5
    6
    7
    8

    Detection of circulating tumor cells in different stages of prostate cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 5, p. 755, doi. 10.1007/s00432-013-1377-5
    By:
    • Thalgott, Mark;
    • Rack, Brigitte;
    • Maurer, Tobias;
    • Souvatzoglou, Michael;
    • Eiber, Matthias;
    • Kreß, Veronika;
    • Heck, Matthias;
    • Andergassen, Ulrich;
    • Nawroth, Roman;
    • Gschwend, Jürgen;
    • Retz, Margitta
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15

    Value of <sup>111</sup>In-prostate-specific membrane antigen ( PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up.

    Published in:
    BJU International, 2017, v. 120, n. 1, p. 40, doi. 10.1111/bju.13713
    By:
    • Rauscher, Isabel;
    • Düwel, Charlotte;
    • Wirtz, Martina;
    • Schottelius, Margret;
    • Wester, Hans ‐ Jürgen;
    • Schwamborn, Kristina;
    • Haller, Bernhard;
    • Schwaiger, Markus;
    • Gschwend, Jürgen E.;
    • Eiber, Matthias;
    • Maurer, Tobias
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Prostate-specific membrane antigen-radioguided surgery salvage lymph node dissection: experience with fifty oligorecurrent prostate cancer patients.

    Published in:
    World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05189-6
    By:
    • Mayr, Roman;
    • Engelmann, Simon Udo;
    • Yang, Yushan;
    • Haas, Maximilian;
    • Schmid, Thomas;
    • Schnabel, Marco Julius;
    • Breyer, Johannes;
    • Schmidt, Daniel;
    • Eiber, Matthias;
    • Denzinger, Stefan;
    • Burger, Maximilian;
    • Hellwig, Dirk;
    • Moosbauer, Jutta;
    • Grosse, Jirka
    Publication type:
    Article
    22

    Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.

    Published in:
    World Journal of Urology, 2023, v. 41, n. 9, p. 2343, doi. 10.1007/s00345-023-04534-5
    By:
    • Falkenbach, Fabian;
    • Knipper, Sophie;
    • Koehler, Daniel;
    • Ambrosini, Francesca;
    • Steuber, Thomas;
    • Graefen, Markus;
    • Budäus, Lars;
    • Eiber, Matthias;
    • Lunger, Lukas;
    • Lischewski, Flemming;
    • Heck, Matthias M.;
    • Maurer, Tobias
    Publication type:
    Article
    23
    24

    Prognostic <sup>18</sup>F-flotufolastat PET parameters for outcome assessment of <sup>177</sup>Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2041, doi. 10.1007/s00259-024-07003-2
    By:
    • Karimzadeh, Amir;
    • Hansen, Kimberley;
    • Hasa, Ergela;
    • Haller, Bernhard;
    • Heck, Matthias M.;
    • Tauber, Robert;
    • D'Alessandria, Calogero;
    • Weber, Wolfgang A.;
    • Eiber, Matthias;
    • Rauscher, Isabel
    Publication type:
    Article
    25
    26

    How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 3, doi. 10.1007/s00259-023-06389-9
    By:
    • Ambrosini, Valentina;
    • Carrilho Vaz, Sofia;
    • Ahmadi Bidakhvidi, Niloefar;
    • Chanchou, Marion;
    • Cysouw, Matthijs C. F.;
    • Serani, Francesca;
    • Voltin, Conrad-Amadeus;
    • Kraeber-Bodere, Francoise;
    • Deroose, Christophe M.;
    • De Geus-Oei, Lioe-Fee;
    • Eiber, Matthias;
    • Gnanasegaran, Gopinath;
    • Gotthardt, Martin;
    • Kobe, Carsten;
    • Konijnenberg, Mark W.;
    • Nanni, Cristina;
    • Oprea Lager, Daniela E.;
    • Rahbar, Kambiz;
    • Taieb, David;
    • Mottaghy, Felix M.
    Publication type:
    Article
    27

    Development and external validation of a multivariable [<sup>68</sup>Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3137, doi. 10.1007/s00259-023-06278-1
    By:
    • Muehlematter, Urs J.;
    • Schweiger, Lilit;
    • Ferraro, Daniela A.;
    • Hermanns, Thomas;
    • Maurer, Tobias;
    • Heck, Matthias M.;
    • Rupp, Niels J.;
    • Eiber, Matthias;
    • Rauscher, Isabel;
    • Burger, Irene A.
    Publication type:
    Article
    28

    Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 9, p. 2830, doi. 10.1007/s00259-023-06255-8
    By:
    • Kratochwil, Clemens;
    • Fendler, Wolfgang P.;
    • Eiber, Matthias;
    • Hofman, Michael S.;
    • Emmett, Louise;
    • Calais, Jeremie;
    • Osborne, Joseph R.;
    • Iravani, Amir;
    • Koo, Phillip;
    • Lindenberg, Liza;
    • Baum, Richard P.;
    • Bozkurt, Murat Fani;
    • Delgado Bolton, Roberto C.;
    • Ezziddin, Samer;
    • Forrer, Flavio;
    • Hicks, Rodney J.;
    • Hope, Thomas A.;
    • Kabasakal, Levent;
    • Konijnenberg, Mark;
    • Kopka, Klaus
    Publication type:
    Article
    29

    Adoption of Lutetium-<sup>177</sup> PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 2188, doi. 10.1007/s00259-023-06139-x
    By:
    • Flegar, Luka;
    • Thoduka, Smita George;
    • Librizzi, Damiano;
    • Luster, Markus;
    • Zacharis, Aristeidis;
    • Heers, Hendrik;
    • Eisenmenger, Nicole;
    • Ahmadzadehfar, Hojjat;
    • Eiber, Matthias;
    • Weber, Wolfgang;
    • Groeben, Christer;
    • Huber, Johannes
    Publication type:
    Article
    30

    PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1466, doi. 10.1007/s00259-022-06089-w
    By:
    • Fendler, Wolfgang P.;
    • Eiber, Matthias;
    • Beheshti, Mohsen;
    • Bomanji, Jamshed;
    • Calais, Jeremie;
    • Ceci, Francesco;
    • Cho, Steve Y.;
    • Fanti, Stefano;
    • Giesel, Frederik L.;
    • Goffin, Karolien;
    • Haberkorn, Uwe;
    • Jacene, Heather;
    • Koo, Phillip J.;
    • Kopka, Klaus;
    • Krause, Bernd J.;
    • Lindenberg, Liza;
    • Marcus, Charles;
    • Mottaghy, Felix M.;
    • Oprea-Lager, Daniela E.;
    • Osborne, Joseph R.
    Publication type:
    Article
    31
    32
    33

    Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4271, doi. 10.1007/s00259-022-05882-x
    By:
    • Gafita, Andrei;
    • Rauscher, Isabel;
    • Fendler, Wolfgang P.;
    • Murthy, Vishnu;
    • Hui, Wang;
    • Armstrong, Wesley R.;
    • Herrmann, Ken;
    • Weber, Wolfgang A.;
    • Calais, Jeremie;
    • Eiber, Matthias;
    • Weber, Manuel;
    • Benz, Matthias R.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Spleen Volume Reduction Is a Reliable and Independent Biomarker for Long-Term Risk of Leukopenia Development in Peptide Receptor Radionuclide Therapy.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1244, doi. 10.2967/jnumed.123.267098
    By:
    • Steinhelfer, Lisa;
    • Jungmann, Friederike;
    • Endrös, Lukas;
    • Wenzel, Patrick;
    • Haller, Bernhard;
    • Nickel, Manuel;
    • Haneder, Eva;
    • Geisler, Fabian;
    • Götze, Katharina;
    • von Werder, Alexander;
    • Eiber, Matthias;
    • Makowski, Markus R.;
    • Braren, Rickmer;
    • Lohöfer, Fabian
    Publication type:
    Article
    40

    Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial).

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1076, doi. 10.2967/jnumed.123.267004
    By:
    • Nikitas, John;
    • Lam, Ethan;
    • Booker, Kiara Adame;
    • Fendler, Wolfgang P.;
    • Eiber, Matthias;
    • Hadaschik, Boris;
    • Herrmann, Ken;
    • Hirmas, Nader;
    • Lanzafame, Helena;
    • Stuschke, Martin;
    • Czernin, Johannes;
    • Steinberg, Michael L.;
    • Nickols, Nicholas G.;
    • Kishan, Amar U.;
    • Calais, Jeremie
    Publication type:
    Article
    41

    RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 917, doi. 10.2967/jnumed.123.267234
    By:
    • Gafita, Andrei;
    • Djaileb, Loic;
    • Rauscher, Isabel;
    • Fendler, Wolfgang P.;
    • Hadaschik, Boris;
    • Rowe, Steven P.;
    • Herrmann, Ken;
    • Solnes, Lilja B.;
    • Calais, Jeremie;
    • Rettig, Matthew B.;
    • Weber, Manuel;
    • Farolfi, Andrea;
    • Benz, Matthias R.;
    • Eiber, Matthias
    Publication type:
    Article
    42
    43

    Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 438, doi. 10.2967/jnumed.123.266391
    By:
    • Farolfi, Andrea;
    • Armstrong, Wesley R.;
    • Djaileb, Loic;
    • Gafita, Andrei;
    • Masatoshi Hotta;
    • Allen-Auerbach, Martin;
    • Unterrainer, Lena M.;
    • Fendler, Wolfgang P.;
    • Rettig, Matthew;
    • Eiber, Matthias;
    • Hofman, Michael S.;
    • Hadaschik, Boris;
    • Herrmann, Ken;
    • Czernin, Johannes;
    • Calais, Jeremie;
    • Benz, Matthias R.
    Publication type:
    Article
    44

    Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266391
    By:
    • Farolfi, Andrea;
    • Armstrong, Wesley R.;
    • Djaileb, Loic;
    • Gafita, Andrei;
    • Hotta, Masatoshi;
    • Allen-Auerbach, Martin;
    • Unterrainer, Lena M.;
    • Fendler, Wolfgang P.;
    • Rettig, Matthew;
    • Eiber, Matthias;
    • Hofman, Michael S.;
    • Hadaschik, Boris;
    • Herrmann, Ken;
    • Czernin, Johannes;
    • Calais, Jeremie;
    • Benz, Matthias R.
    Publication type:
    Article
    45

    Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 94, doi. 10.2967/jnumed.123.266164
    By:
    • Emmett, Louise;
    • Pa, Nathan;
    • Counter, William;
    • Calais, Jeremie;
    • Barbato, Francesco;
    • Burger, Irene;
    • Eiber, Matthias;
    • Roberts, Matthew J.;
    • Agrawal, Shikha;
    • Franklin, Anthony;
    • Xue, Alan;
    • Rasiah, Krishan;
    • John, Nikeith;
    • Moon, Daniel;
    • Frydenberg, Mark;
    • Yaxley, John;
    • Stricker, Phillip;
    • Wong, Keith;
    • Coughlin, Geoff;
    • Gianduzzo, Troy
    Publication type:
    Article
    46

    Long-Term Nephrotoxicity of <sup>177</sup>Lu-PSMA Radioligand Therapy.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 79, doi. 10.2967/jnumed.123.265986
    By:
    • Steinhelfer, Lisa;
    • Lunger, Lukas;
    • Cala, Lisena;
    • Pfob, Christian H.;
    • Lapa, Constantin;
    • Hartrampf, Philipp E.;
    • Buck, Andreas K.;
    • Schäfer, Hannah;
    • Schmaderer, Christoph;
    • Tauber, Robert;
    • Brosch-Lenz, Julia;
    • Haller, Bernhard;
    • Meissner, Valentin H.;
    • Knorr, Karina;
    • Weber, Wolfgang A.;
    • Eiber, Matthias
    Publication type:
    Article
    47
    48

    <sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study).

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1925, doi. 10.2967/jnumed.123.266125
    By:
    • Rahbar, Kambiz;
    • Essler, Markus;
    • Eiber, Matthias;
    • la Fougère, Christian;
    • Prasad, Vikas;
    • Fendler, Wolfgang P.;
    • Rassek, Philipp;
    • Hasa, Ergela;
    • Dittmann, Helmut;
    • Bundschuh, Ralph A.;
    • Pabst, Kim M.;
    • Kurtinecz, Milena;
    • Schmall, Anja;
    • Verholen, Frank;
    • Sartor, Oliver
    Publication type:
    Article
    49
    50

    PSMA Is Not Specific to Prostate Cancer.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1326, doi. 10.2967/jnumed.123.265921
    By:
    • Notohamiprodjo, Susan;
    • Eiber, Matthias;
    • Lohrmann, Christian;
    • Weber, Wolfgang A.
    Publication type:
    Article